CompletedNot Applicable

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

United States8 participantsStarted 2022-10-19

Plain-language summary

Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with left-sided breast cancers * Patients must be undergoing left breast/chest wall radiation with or without regional nodal irradiation * Patients undergoing lung SBRT * Primary lung cancers * Metastatic lung tumors Exclusion Criteria: * Patients with right side breast cancer * Patients who are unable to tolerate the CPAP device

What they're measuring

Dosimetry comparison CPAP and free breathing.

Timeframe: At the time of Scan, " Day 1"

Dosimetry comparison CPAP and free breathing.

Timeframe: At the time of Scan, " Day 1"

Dosimetry comparison CPAP and free breathing.

Timeframe: At the time of Scan, " Day 1"

Trial details

NCT IDNCT05142358

SponsorCase Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-28

View on ClinicalTrials.gov More Lung Cancer trials